Third degree atrioventricular block associated with treatment with rivastigmine transdermal patch
Rivastigmine transdermal patch is indicated for patients with Alzheimer's disease and dementia with Parkinson's disease. Rivastigmine, an acetylcholinesterase inhibitor, has several common adverse effects, mainly involving the gastrointestinal tract, but few cardiovascular adverse effects...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Science Press
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627713/ |